From The Cancer Chronicles #18
© November 1993 by Ralph W. Moss, Ph.D.


Charles Moertel is known as an opponent of alternative cancer treatments. He oversaw the Mayo Clinic¹s negative trials of both laetrile and vitamin C. Now, however, he has found an unlikely target: the giant U.S. company that manufactures the drug levamisole.

In 1989, Dr. Moertel made headlines when he championed the use of 5-FU and levamisole (an animal de-wormer) as the treatment of choice for advanced colon cancer. At a meeting in Washington he handed over his clinical test results on levamisole to Johnson & Johnson, the $12 billion-a-year health care giant that holds a patent on the drug's use in cancer.

"I will do everything I can to help get this treatment to patients," he told assembled NCI, FDA and J&J officials. "In return, IŠwant a promise from Johnson & Johnson that you will market this at a reasonable price. I assumed they were honest and honorable people," he now says, in a detailed account in the Los Angeles Times (9/11/93).

Nine months later, however, he learned that J&J had increased the price of levamisole one hundredfold. For animals, it costs 6 cents per pill; as a human cancer drug, $6.00. A year's supply for a sheep costs $1.00; for humans, $1,200.00.

"So began the transformation," says the Los Angeles Times, "of a trusting Mayo Clinic researcher into an outraged, outspoken industry critic." But so far, J&J has refused to budge on the price. "We're the only Western nation that doesn¹t regulate drug prices," Moertel fumes. "This is out of hand. This is nonsense."


articles on people and cancer

Ralph W. Moss, Ph.D. is director of the The Moss Reports for cancer patients. Dr. Moss is the author of eleven books and three documentaries on cancer-related topics. He is or has been an advisor on alternative cancer treatments to the National Institutes of Health, the National Cancer Institute, the American Urological Association, Columbia University, the University of Texas, the Susan G. Komen Foundation and the German Society of Oncology. He wrote the first article on alternative medicine for the Encyclopedia Britannica yearbook. He is listed in Marquis Who's Who in America, Who's Who in the World, Who's Who in the East, and Who's Who in Entertainment (as a film documentarian). This Web site does not advocate any particular treatment for cancer. We urge you to always seek competent medical advice for all health problems, especially cancer. Before consulting our site please read our full Disclaimer statement.

home - moss reports - books - - contact - order - news
members - chronicles - faq - free email newsletter